CTT Pharmaceutical Holdings (CTTH) Stock Overview
Engages in the development of oral drug delivery systems for pain management and treatment. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
CTTH Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
CTT Pharmaceutical Holdings, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.08 |
| 52 Week High | US$0.13 |
| 52 Week Low | US$0.017 |
| Beta | 0.50 |
| 1 Month Change | 72.45% |
| 3 Month Change | 13.90% |
| 1 Year Change | -33.75% |
| 3 Year Change | 127.14% |
| 5 Year Change | 25.69% |
| Change since IPO | -81.07% |
Recent News & Updates
Recent updates
Shareholder Returns
| CTTH | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | 10.6% | 1.2% | -0.4% |
| 1Y | -33.8% | 27.6% | 12.7% |
Return vs Industry: CTTH underperformed the US Pharmaceuticals industry which returned 27.6% over the past year.
Return vs Market: CTTH underperformed the US Market which returned 12.7% over the past year.
Price Volatility
| CTTH volatility | |
|---|---|
| CTTH Average Weekly Movement | 30.5% |
| Pharmaceuticals Industry Average Movement | 9.9% |
| Market Average Movement | 6.5% |
| 10% most volatile stocks in US Market | 16.3% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: CTTH's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: CTTH's weekly volatility (31%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 1 | Ryan Khouri | www.cttpharmaceuticals.com |
CTT Pharmaceutical Holdings, Inc. engages in the development of oral drug delivery systems for pain management and treatment. It focuses on fast dissolving drug delivery systems. The company’s technology platform includes the development of advanced oral delivery thin wafers infused with both natural and/or synthetic cannabis extracts to deliver treatment as an alternate to smoking and ingestion.
CTT Pharmaceutical Holdings, Inc. Fundamentals Summary
| CTTH fundamental statistics | |
|---|---|
| Market cap | US$4.68m |
| Earnings (TTM) | -US$152.54k |
| Revenue (TTM) | n/a |
Is CTTH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CTTH income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$0 |
| Gross Profit | US$0 |
| Other Expenses | US$152.54k |
| Earnings | -US$152.54k |
Last Reported Earnings
Sep 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.0026 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 20.8% |
How did CTTH perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/01/26 08:23 |
| End of Day Share Price | 2026/01/23 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
CTT Pharmaceutical Holdings, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.